Literature DB >> 17886312

The enantioselective synthesis of phomopsin B.

Joshua S Grimley1, Andrew M Sawayama, Hiroko Tanaka, Michelle M Stohlmeyer, Thomas F Woiwode, Thomas J Wandless.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17886312      PMCID: PMC3290521          DOI: 10.1002/anie.200702537

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  10 in total

1.  Total synthesis of ustiloxin D.

Authors:  Bin Cao; Haengsoon Park; Madeleine M Joullié
Journal:  J Am Chem Soc       Date:  2002-01-30       Impact factor: 15.419

2.  Enantioselective total synthesis of ustiloxin D.

Authors:  Hiroko Tanaka; Andrew M Sawayama; Thomas J Wandless
Journal:  J Am Chem Soc       Date:  2003-06-11       Impact factor: 15.419

Review 3.  Microtubules as a target for anticancer drugs.

Authors:  Mary Ann Jordan; Leslie Wilson
Journal:  Nat Rev Cancer       Date:  2004-04       Impact factor: 60.716

4.  A convergent total synthesis of ustiloxin D via an unprecedented copper-catalyzed ethynyl aziridine ring-opening by phenol derivatives.

Authors:  Pixu Li; Cory D Evans; Madeleine M Joullié
Journal:  Org Lett       Date:  2005-11-10       Impact factor: 6.005

5.  Synthesis and anti-tubulin activity of ustiloxin D derivatives.

Authors:  N Morisaki; Y Mitsui; Y Yamashita; Y Koiso; R Shirai; Y Hashimoto; S Iwasaki
Journal:  J Antibiot (Tokyo)       Date:  1998-04       Impact factor: 2.649

Review 6.  Antimitotic agents: chemistry and recognition of tubulin molecule.

Authors:  S Iwasaki
Journal:  Med Res Rev       Date:  1993-03       Impact factor: 12.944

7.  Chiral Salen-Aluminum Complexes as Catalysts for Enantioselective Aldol Reactions of Aldehydes and 5-Alkoxyoxazoles: An Efficient Approach to the Asymmetric Synthesis of syn and anti beta-Hydroxy-alpha-amino Acid Derivatives Financial support has been provided by the National Institutes of Health (GM 43912-11 and GM 33328-18).

Authors:  David A. Evans; Jacob M. Janey; Nabi Magomedov; Jason S. Tedrow
Journal:  Angew Chem Int Ed Engl       Date:  2001-05-18       Impact factor: 15.336

8.  Total synthesis of ustiloxin D and considerations on the origin of selectivity of the asymmetric allylic alkylation.

Authors:  Andrew M Sawayama; Hiroko Tanaka; Thomas J Wandless
Journal:  J Org Chem       Date:  2004-12-10       Impact factor: 4.354

9.  Isolation of toxic metabolites of Phomopsis leptostromiformis responsible for lupinosis.

Authors:  C C Culvenor; A B Beck; M Clarke; P A Cockrum; J A Edgar; J L Frahn; M V Jago; G W Lanigan; A L Payne; J E Peterson; D S Petterson; L W Smith; R R White
Journal:  Aust J Biol Sci       Date:  1977-08

10.  Ustiloxins, antimitotic cyclic peptides from false smut balls on rice panicles caused by Ustilaginoidea virens.

Authors:  Y Koiso; Y Li; S Iwasaki; K Hanaoka; T Kobayashi; R Sonoda; Y Fujita; H Yaegashi; Z Sato
Journal:  J Antibiot (Tokyo)       Date:  1994-07       Impact factor: 2.649

  10 in total
  4 in total

1.  A Copper-Carbodiimide Approach to the Phomopsin Tripeptide Side Chain.

Authors:  Ning Shangguan; Madeleine Joullié
Journal:  Tetrahedron Lett       Date:  2009-12-09       Impact factor: 2.415

2.  Efficient synthesis of oxazoles by dirhodium(II)-catalyzed reactions of styryl diazoacetate with oximes.

Authors:  Xinfang Xu; Peter Y Zavalij; Wenhao Hu; Michael P Doyle
Journal:  Chem Commun (Camb)       Date:  2012-12-07       Impact factor: 6.222

3.  Convergent Total Synthesis of Yaku'amide A.

Authors:  Yu Cai; Zhiwei Ma; Jintao Jiang; Concordia C L Lo; Shi Luo; Ankur Jalan; Joseph M Cardon; Alexander Ramos; Diego A Moyá; Daniel Joaquin; Steven L Castle
Journal:  Angew Chem Int Ed Engl       Date:  2021-01-21       Impact factor: 15.336

4.  Synthesis and evaluation of potent yaku'amide A analogs.

Authors:  Concordia C L Lo; Daniel Joaquin; Diego A Moyá; Alexander Ramos; David W Kastner; Stephen M White; Blake L Christensen; Joseph G Naglich; William J Degnen; Steven L Castle
Journal:  Chem Sci       Date:  2022-01-03       Impact factor: 9.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.